Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03003676 |
|---|---|
| Brief Title: | A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade |
| First Submitted : | December 19, 2016 |
| First Submitted that Met QC Criteria : | December 21, 2016 |
| First Posted : | December 28, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 6, 2020 |
| Last Update Posted : | October 8, 2020 |